BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19017760)

  • 41. Evaluation of two new surrogate indices including parameters not using insulin to assess insulin sensitivity/resistance in non-diabetic postmenopausal women: a MONET group study.
    Bastard JP; Lavoie ME; Messier V; Prud'homme D; Rabasa-Lhoret R
    Diabetes Metab; 2012 Jun; 38(3):258-63. PubMed ID: 22405724
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effectiveness of Genistein Supplementation on Metabolic Factors and Antioxidant Status in Postmenopausal Women With Type 2 Diabetes Mellitus.
    Braxas H; Rafraf M; Karimi Hasanabad S; Asghari Jafarabadi M
    Can J Diabetes; 2019 Oct; 43(7):490-497. PubMed ID: 31307913
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Menopause, insulin resistance, and risk factors for cardiovascular disease.
    Manco M; Nolfe G; Calvani M; Natali A; Nolan J; Ferrannini E; Mingrone G;
    Menopause; 2006; 13(5):809-17. PubMed ID: 16900080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of soy isoflavones and genistein on glucose metabolism in perimenopausal and postmenopausal non-Asian women: a meta-analysis of randomized controlled trials.
    Ricci E; Cipriani S; Chiaffarino F; Malvezzi M; Parazzini F
    Menopause; 2010; 17(5):1080-6. PubMed ID: 20581723
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral, transdermal and vaginal combined contraceptives induce an increase in markers of chronic inflammation and impair insulin sensitivity in young healthy normal-weight women: a randomized study.
    Piltonen T; Puurunen J; Hedberg P; Ruokonen A; Mutt SJ; Herzig KH; Nissinen A; Morin-Papunen L; Tapanainen JS
    Hum Reprod; 2012 Oct; 27(10):3046-56. PubMed ID: 22811306
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relation of direct and surrogate measures of insulin resistance to cardiovascular risk factors in nondiabetic finnish offspring of type 2 diabetic individuals.
    Lorenzo C; Haffner SM; Stancáková A; Laakso M
    J Clin Endocrinol Metab; 2010 Nov; 95(11):5082-90. PubMed ID: 20702522
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identifying metabolically healthy but obese individuals in sedentary postmenopausal women.
    Messier V; Karelis AD; Prud'homme D; Primeau V; Brochu M; Rabasa-Lhoret R
    Obesity (Silver Spring); 2010 May; 18(5):911-7. PubMed ID: 19851302
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison between several insulin sensitivity indices and metabolic risk factors in overweight and obese postmenopausal women: a MONET study.
    Malita FM; Messier V; Lavoie JM; Bastard JP; Rabasa-Lhoret R; Karelis AD
    Nutr Metab Cardiovasc Dis; 2010 Mar; 20(3):173-9. PubMed ID: 19501492
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improvement of insulin sensitivity by metformin treatment does not lower blood pressure of nonobese insulin-resistant hypertensive patients with normal glucose tolerance.
    Dorella M; Giusto M; Da Tos V; Campagnolo M; Palatini P; Rossi G; Ceolotto G; Felice M; Semplicini A; Del Prato S
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1568-74. PubMed ID: 8636369
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of insulin sensitivity from measurements in the fasting state and during an oral glucose tolerance test in polycystic ovary syndrome and menopausal patients.
    Ciampelli M; Leoni F; Cucinelli F; Mancuso S; Panunzi S; De Gaetano A; Lanzone A
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1398-406. PubMed ID: 15598698
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study.
    Squadrito F; Altavilla D; Crisafulli A; Saitta A; Cucinotta D; Morabito N; D'Anna R; Corrado F; Ruggeri P; Frisina N; Squadrito G
    Am J Med; 2003 Apr; 114(6):470-6. PubMed ID: 12727580
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low- and standard-estrogen dosage in oral therapy: dose-dependent effects on insulin and lipid metabolism in healthy postmenopausal women.
    Villa P; Sagnella F; Perri C; Suriano R; Costantini B; Macrí F; Ricciardi L; Lanzone A
    Climacteric; 2008; 11(6):498-508. PubMed ID: 18991077
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The effects of ethinyl estradiol on glucose metabolism in postmenopausal women].
    Wu J; Bi Y; Wang H
    Zhonghua Fu Chan Ke Za Zhi; 1997 Sep; 32(9):528-31. PubMed ID: 9639751
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nocturnal blood pressure but not insulin resistance influences endothelial function in treated hypertensive patients.
    Konrad T; Franke S; Schneider F; Bär F; Vetter G; Winkler K
    J Hum Hypertens; 2011 Jan; 25(1):18-24. PubMed ID: 20237501
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between the hyperinsulinemic-euglycaemic clamp and a new simple index assessing insulin sensitivity in overweight and obese postmenopausal women.
    Bastard JP; Vandernotte JM; Faraj M; Karelis AD; Messier L; Malita FM; Garrel D; Prud'homme D; Rabasa-Lhoret R
    Diabetes Metab; 2007 Sep; 33(4):261-8. PubMed ID: 17499540
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of glucose homeostasis in humans with denervated livers.
    Perseghin G; Regalia E; Battezzati A; Vergani S; Pulvirenti A; Terruzzi I; Baratti D; Bozzetti F; Mazzaferro V; Luzi L
    J Clin Invest; 1997 Aug; 100(4):931-41. PubMed ID: 9259593
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study.
    D'Anna R; Cannata ML; Atteritano M; Cancellieri F; Corrado F; Baviera G; Triolo O; Antico F; Gaudio A; Frisina N; Bitto A; Polito F; Minutoli L; Altavilla D; Marini H; Squadrito F
    Menopause; 2007; 14(4):648-55. PubMed ID: 17251874
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of nonoral estradiol-micronized progesterone or low-dose oral estradiol-drospirenone therapy on metabolic variables and markers of endothelial function in early postmenopause.
    Casanova G; Radavelli S; Lhullier F; Spritzer PM
    Fertil Steril; 2009 Aug; 92(2):605-12. PubMed ID: 18706557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.